Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
After watching X’s ownership issues play out, marketers brace for TikTok whiplash in 2026
TikTok’s ownership drama has echoes of X (formerly Twitter), but ad performance has kept marketers for fleeing—for now.
‘There’s no room for purists’: Generative AI is altering the agency junior talent search
AI is altering agency business models. It’s altering the skills they’re hiring for and where they’re hiring them from, too.
For platforms, here’s what’s not going to happen in 2026
Rather than the traditional platform predictions, this is a list of what Digiday believes won’t happen next year.